跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,767 条关于
“ARO-MAPT”
全部
7,767
临床试验
6,545
药物
607
机构
90
资讯
525
去年
Arrowhead Pharmaceuticals Advances Two Breakthrough RNAi Therapeutics into Clinical Trials
去年
Arrowhead Seeks FDA Approval for Plozasiran in Familial Chylomicronemia Syndrome
9个月前
Arrowhead Pharmaceuticals Achieves FDA Approval for Rodemplo, Reports Strong Financial Turnaround
8个月前
Arrowhead Pharmaceuticals Reports Strong Q1 2026 Results with REDEMPLO Launch Success and Promising Obesity Pipeline Data
去年
Arrowhead Pharmaceuticals' FDA Acceptance of Plozasiran NDA Marks Milestone in RNAi Therapeutics
2年前
Arrowhead Pharmaceuticals Advances RNAi Therapies ARO-INHBE and ARO-ALK7 for Obesity Treatment
去年
Arrowhead Pharmaceuticals Launches First-in-Human Trial of ARO-ALK7 for Obesity Treatment
去年
Arrowhead Pharmaceuticals Receives $100 Million Milestone Payment for ARO-DM1 Myotonic Dystrophy Treatment
去年
Arrowhead's ARO-C3 Shows Promising Results in IgA Nephropathy Trial with 89% Reduction in C3 Levels
去年
Arrowhead Initiates Phase I/IIa Trial of RNAi Therapy ARO-INHBE for Obesity
第 1 页,共 53 页
上一页
下一页